Atlas Trials

Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation

Clinical trial NCT01841632 · TERMINATED

Trial details

NCT number
NCT01841632
Sponsor
Prof. Dr. Marc-H. Dahlke, Ph. D.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Liver Transplantation
Start date
2013-04-01
Primary completion
2016-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.